{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:19:17Z","timestamp":1774365557042,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12889-016-3557-0","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T13:22:31Z","timestamp":1472131351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mortality among tuberculosis patients under DOTS programme: a historical cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Yeshiwork","family":"Beyene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berhanu","family":"Geresu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assefa","family":"Mulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"3557_CR1","volume-title":"Global Tuberculosis control report","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Global Tuberculosis control report. 20th ed. Geneva: WHO; 2015.","edition":"20"},{"key":"3557_CR2","volume-title":"Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia","author":"Federal Minister of Health","year":"2007","unstructured":"Federal Minister of Health. Implementation Guideline for TB\/HIV Collaborative Activities in Ethiopia. Addis Ababa: Federal Ministry of Health; 2007."},{"key":"3557_CR3","volume-title":"Guidelines for clinical and programmatic management of TB, TB\/HIV and leprosy in Ethiopia","author":"Federal Ministry of Health","year":"2012","unstructured":"Federal Ministry of Health. Guidelines for clinical and programmatic management of TB, TB\/HIV and leprosy in Ethiopia. 5th ed. Addis Ababa: Federal Ministry of Health; 2012.","edition":"5"},{"key":"3557_CR4","volume-title":"Treatment of tuberculosis: Guidelines for National Programmes","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Treatment of tuberculosis: Guidelines for National Programmes. 4th ed. Geneva: WHO; 2010.","edition":"4"},{"key":"3557_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2334-13-297","volume":"13","author":"B Sileshi","year":"2013","unstructured":"Sileshi B, Deyessa N, Girma B, Melese M, Suarez P. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis. 2013;13:297.","journal-title":"BMC Infect Dis"},{"key":"3557_CR6","volume-title":"Framework for effective tuberculosis control","author":"World Health Organization","year":"1994","unstructured":"World Health Organization. Framework for effective tuberculosis control. Geneva: WHO; 1994."},{"key":"3557_CR7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(95)90519-7","volume":"345","author":"AN Ackah","year":"1995","unstructured":"Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM, Greenberg AE, De Cock KM. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d\u2019Ivoire. Lancet. 1995;345:607\u201310.","journal-title":"Lancet"},{"key":"3557_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","volume":"151","author":"C Whalen","year":"1995","unstructured":"Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated clinical course of HIV infection after tuberculosis. Am J Respir Crit Care Med. 1995;151:129\u201335.","journal-title":"Am J Respir Crit Care Med"},{"key":"3557_CR9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002030-199603000-00005","volume":"10","author":"RW Shafer","year":"1996","unstructured":"Shafer RW, Bloch AB, Larkin C, Vasudavan V, Seligman S, Dehovitz JD, DiFerdinando G, Stoneburner R, Cauthen G. Predictors of survival in HIV-infected tuberculosis patients. AIDS. 1996;10:269\u201372.","journal-title":"AIDS"},{"key":"3557_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2334-11-127","volume":"11","author":"B Getahun","year":"2011","unstructured":"Getahun B, Ameni G, Biadgilign S, Medhin G. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia. BMC Infect Dis. 2011;11:127.","journal-title":"BMC Infect Dis"},{"key":"3557_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2458-9-371","volume":"9","author":"B Tessema","year":"2009","unstructured":"Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U. Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - year retrospective study. BMC Publ Health. 2009;9:371.","journal-title":"BMC Publ Health"},{"key":"3557_CR12","first-page":"372","volume":"2","author":"JP Zellweger","year":"1998","unstructured":"Zellweger JP, Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis. 1998;2:372\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3557_CR13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/1756-0500-5-682","volume":"5","author":"D Shaweno","year":"2012","unstructured":"Shaweno D, Worku A. Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: A retrospective cohort study. BMC Res Notes. 2012;5:682.","journal-title":"BMC Res Notes"},{"key":"3557_CR14","unstructured":"Mahajan V, Verma SK. HIV-Tuberculosis co-infection. The Internet Journal of Pulmonary Medicine 2008, http:\/\/www.ispub.com Accessed Jul 12 2013."},{"key":"3557_CR15","doi-asserted-by":"crossref","first-page":"e21008","DOI":"10.1371\/journal.pone.0021008","volume":"6","author":"S Vijay","year":"2011","unstructured":"Vijay S, Kumar P, Chauhan LS, Narayan Rao SV, Vaidyanathan P. Treatment outcome and mortality at one and half year follow-Up of HIV infected TB patients under TB control programme in a District of South India. PLoS One. 2011;6:e21008.","journal-title":"PLoS One"},{"key":"3557_CR16","first-page":"6","volume":"13","author":"AD Harries","year":"2009","unstructured":"Harries AD, Zachariah R, Lawn SD. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis. 2009;13:6\u201316.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3557_CR17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00002030-200106150-00009","volume":"15","author":"M Badri","year":"2001","unstructured":"Badri M, Ehrlich R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO\/UNAIDS recommendations. AIDS. 2001;15:1143\u20138.","journal-title":"AIDS"},{"key":"3557_CR18","volume-title":"Guideline on cotrimoxazole prophylaxis for HIV related infections among children, adolescent & adults","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Guideline on cotrimoxazole prophylaxis for HIV related infections among children, adolescent & adults. 2nd ed. Geneva: WHO; 2009.","edition":"2"},{"key":"3557_CR19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3201\/eid1502.080942","volume":"15","author":"KP Cain","year":"2009","unstructured":"Cain KP, Anekthananon T, Burapat C, Akksilp S, Mankhatitham W, Srinak C, Nateniyom S, Sattayawuthipong W, Tasaneeyapan T, Varma JK. Causes of death in HIV-infected persons who have tuberculosis, Thailand. Emerg Infect Dis. 2009;15:258\u201364.","journal-title":"Emerg Infect Dis"},{"key":"3557_CR20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/tmi.12110","volume":"18","author":"AJ Stockdale","year":"2013","unstructured":"Stockdale AJ, Nkuranga J, T\u00f6r\u00f6k ME, Faragher B, Lalloo DG. Initiation of Antiretroviral Therapy in HIV-Infected Tuberculosis Patients in Rural Kenya: An Observational Study. Trop Med Int Health. 2013;18:907\u201314.","journal-title":"Trop Med Int Health"},{"key":"3557_CR21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COH.0b013e32832c7d61","volume":"4","author":"SD Lawn","year":"2009","unstructured":"Lawn SD, Churchyard G. Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS. 2009;4:325\u201333.","journal-title":"Curr Opin HIV AIDS"},{"key":"3557_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","volume":"43","author":"W Manosuthi","year":"1999","unstructured":"Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV\/tuberculosis coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr. 1999;43:42\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3557_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31819367e7","volume":"50","author":"M Velasco","year":"1999","unstructured":"Velasco M, Castilla V, Sanz J, Gaspar G, Condes E, Barros C, Cervero M, Torres R, Guijarro C. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr. 1999;50:148\u201352.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3557_CR24","first-page":"797","volume":"9","author":"K Tocque","year":"2005","unstructured":"Tocque K, Convrey RP, Bellis MA, Beeching NJ, Davies PD. Elevated mortality following diagnosis with a treatable disease: tuberculosis. Int J Tuberc Lung Dis. 2005;9:797\u2013801.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3557_CR25","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1183\/09031936.00131107","volume":"31","author":"N Lefebvre","year":"2008","unstructured":"Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008;31:1256\u201360.","journal-title":"Eur Respir J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-016-3557-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T21:22:08Z","timestamp":1498339328000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-016-3557-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3557"],"URL":"https:\/\/doi.org\/10.1186\/s12889-016-3557-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]},"article-number":"883"}}